Predicting the risk of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy: Validating the CAMD and AASL scores in China

Predicting the risk of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy: Validating the CAMD and AASL scores in China

Background: We aimed to validate the predictive value of the cirrhosis, age, male sex, and diabetes (CAMD) score and age, albumin, sex, and liver cirrhosis (AASL) score for chronic hepatitis B (CHB) patients, treated with nucleos(t)ide analogues (NUCs) in Northeast China. Methods: From January 2009...

Full description

Bibliographic Details
Main Authors: Shuai Wang, Bingwei Liu, Xuemei Fan, Yang Gao, Mingqi Hong, Yan Xu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
age
albumin
chronic hepatitis b
cirrhosis
diabetes score
hepatocellular carcinoma
sex
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2022;volume=28;issue=5;spage=362;epage=368;aulast=Wang

Internet

http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2022;volume=28;issue=5;spage=362;epage=368;aulast=Wang

Similar Items